Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Dyskinesias

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Dyskinesias:

Pubmed Logo
Transient gender-related effects in Parkinson's disease patients with subthalamic stimulation.
Little is known about the gender-related long-term efficacy and safety...
19th November, 2009
Universita Cattolica del J Neurol. 2009 Nov 18.
DOI Direct Link
Impaired awareness of movement disorders in Parkinson's disease.
BACKGROUND: This study analyzed the presence of awareness of movement...
17th November, 2009
Department of Psychology, University of Torino, Via Verdi 10, 10123 Brain Cogn. 2009 Nov 13.
DOI Direct Link
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
Dopamine is an essential neurotransmitter for many brain functions, and...
17th November, 2009
Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University Lancet Neurol. 2009 Dec;8(12):1140-9.
DOI Direct Link
Predictors of poor neurologic outcome after induced mild hypothermia following cardiac arrest.
Parkinson''s disease (PD) is a neurodegenerative disorder characterised by...
17th November, 2009
Neurology. 2009 Sep 22;73(12):997-8; author reply 998.
DOI Direct Link
Levodopa-induced dyskinesias detection based on the complexity of involuntary movements.
Complexity of the biological system output reflects the system's ability...
3rd November, 2009
Clinical Neurological Sciences, University of Western Ontario, London, J Neurosci Methods. 2009 Oct 28.
DOI Direct Link

View more research publications.

Press Releases About Dyskinesias:

BioPortfolio Logo
Michael J. Fox Foundation Awards $2.5 Million for Parkinson's Drug Development Projects Led By Academic Investigators 27th January, 2009 Michael J. Fox Foundation
NEW YORK, Jan. 27 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research has awarded $2.5 million total for seven Parkinson's drug development projects. The

Dyskinesias Patents:

USPTO Logo
US Patent No.Title
7541361 N-[4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use
7566735 Compounds which potentiate AMPA receptor and uses thereof in medicine
7572785 Substituted imidazoles as cannabinoid receptor modulators
7572792 Azetidine glycine transporter inhibitors
7572819 Compounds which potentiate glutamate receptor and uses thereof in medicine

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Dyskinesias scientists - we have details of around 281 individuals working on Dyskinesias .


This page has been viewed 336 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Dyskinesias across BioPortfolio, or for Dyskinesias Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.